Figure 1.
Minimal residual disease monitoring by allele-specific oligonucleotide-nested-polymerase chain reaction. PCR: polymerase chain reaction; TRM: transplant-related mortality; CT: chemotherapy; mAb: monoclonal antibody; DLI: donor lymphocyte infusion; CSA: cyclosporine; GVHD: graft-versus-host disease.